Article

Mass Spectrometry in Cerebrospinal Fluid Uncovers Association of Glycolysis Biomarkers with Alzheimer’s Disease in a Large Clinical Sample

2023-06-27

Abstract excerpt

<h4>Background: </h4> Alzheimer’s disease (AD) is a complex heterogenous neurodegenerative disorder, characterized by multiple pathophysiologies, including disruptions in brain metabolism. Defining markers for patient stratification across these pathophysiologies is an important step towards personalized treatment of AD. Efficient brain glucose metabolism is essential to sustain neuronal activity, but hypometaboli...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fbce713b-4754-57f7-a728-2781331b61dd
DOI: 10.21203/rs.3.rs-3073597/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Mass Spectrometry in Cerebrospinal Fluid Uncovers Association of Glycolysis Biomarkers with Alzheimer’s Disease in a Large Clinical SampleDOI 10.21203/rs.3.rs-3073597/v1Read

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's diseaseSemantic proximity Read

Large-scale proteome and metabolome analysis of CSF implicates altered glucose metabolism and succinylcarnitine in Alzheimer’s diseaseSemantic proximity Read

A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer’s disease pathologySemantic proximity Read

Proteomic Network Analysis of Alzheimer’s Disease Cerebrospinal Fluid Reveals Alterations Associated with <i>APOE</i> ε4 Genotype and Atomoxetine TreatmentSemantic proximity Read

Alzheimer’s disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expressionSemantic proximity Read

Alteration of Metabolic Profile During the Progression of Alzheimer’s DiseaseSemantic proximity Read

Identification and Validation of Metabolism-Related Genes in Alzheimer’s DiseaseSemantic proximity Read

Metabolic Trans-Omic Analysis Reveals Key Regulatory Disruption of Energy Metabolism in Alzheimer’s DiseaseSemantic proximity Read

Identification of metabolism-related subtypes and feature genes in Alzheimer’s diseaseSemantic proximity Read

Untargeted metabolomics reveals sugar and homocysteine dysregulations in prodromal ADSemantic proximity Read

Tandem mass spectrometry-based identification of protein profiles in the cerebrospinal fluid of Alzheimer’s dementia patientsSemantic proximity Read

Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition and energy metabolism – A validation studySemantic proximity Read